UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | F | H | K | L | M | O | P | Q | R | S | T | W
Number of items: 60.

A

Alam-Faruque, Y; Huntley, RP; Khodiyar, VK; Camon, EB; Dimmer, EC; Sawford, T; Martin, MJ; ... Lovering, RC; + view all (2011) The impact of focused Gene Ontology curation of specific mammalian systems. PLOS One , 6 (12) , Article e27541. 10.1371/journal.pone.0027541. Green open access
file

Apweiler, R; Martin, MJ; O'Donovan, C; Magrane, M; Alam-Faruque, Y; Antunes, R; Barrell, D; ... Zhang, J; + view all (2011) Ongoing and future developments at the Universal Protein Resource. NUCLEIC ACIDS RESEARCH , 39 D214-D219. 10.1093/nar/gkq1020. Gold open access

B

Babu, GG; Walker, JM; Yellon, DM; Hausenloy, DJ; (2011) Peri-procedural myocardial injury during percutaneous coronary intervention: an important target for cardioprotection. EUR HEART J , 32 (1) 23 - +. 10.1093/eurheartj/ehq393.

Bauer, A; Postrach, J; Abicht, J-M; Buchholz, S; Thormann, M; Blanck, S; Kessler, B; ... Brenner, P; + view all (2011) Consistent survival up to 19 days in a heterotopic thoracic pig-to-baboon cardiac xenotransplantation model. In: (Proceedings) Joint International Congress of the Cell-Transplant-Society(CTS)/International-Xenotransplantation-Association (IXA). (pp. pp. 285-286). WILEY-BLACKWELL

Bell, RM; Hendry, C; Bruce-Hickman, D; Davidson, S; Breckenridge, R; Yellon, DM; (2011) MATRIX METALLOPROTEINASE INHIBITION IS A PARALLEL PATHWAY TO PROTECTION AGAINST REPERFUSION INJURY, BOTH INDEPENDENT AND ADDITIVE TO MITOCHONDRIAL PERMEABILITY TRANSITION PORE INHIBITION. HEART , 97 (24) 10.1136/heartjnl-2011-301156.16.

Bell, RM; Mocanu, MM; Yellon, DM; (2011) Retrograde heart perfusion: The Langendorff technique of isolated heart perfusion. J MOL CELL CARDIOL , 50 (6) 940 - 950. 10.1016/j.yjmcc.2011.02.018.

Bell, RM; Yellon, DM; (2011) There is More to Life than Revascularization: Therapeutic Targeting of Myocardial Ischemia/Reperfusion Injury. CARDIOVASCULAR THERAPEUTICS , 29 (6) E67-E79. 10.1111/j.1755-5922.2010.00190.x.

Blake, JA; Dolan, M; Drabkin, H; Hill, DP; Ni, L; Sitnikov, D; Burgess, S; ... Consortium, GO; + view all (2011) The Gene Ontology: enhancements for 2011. NUCLEIC ACIDS RESEARCH , 40 (D1) D559 - D564. 10.1093/nar/gkr1028. Green open access
file

Boilson, BA; McGregor, CGA; Kushwaha, SS; (2011) Pathophysiological changes after cardiac transplantation: the role of chronic inflammation and rejection. B M J PUBLISHING GROUP

Bush, EL; Barbas, AS; Holzknecht, ZE; Byrne, GW; McGregor, CG; Parker, W; Davis, RD; (2011) Coagulopathy in alpha-galactosyl transferase knockout pulmonary xenotransplants. XENOTRANSPLANTATION , 18 (1) 6 - 13. 10.1111/j.1399-3089.2011.00621.x.

Byrne, GW; Du, ZJ; Sun, ZF; Asmann, YW; McGregor, CGA; (2011) Changes in cardiac gene expression after pig-to-primate orthotopic xenotransplantation. XENOTRANSPLANTATION , 18 (1) 14 - 27. 10.1111/j.1399-3089.2010.00620.x.

Byrne, GW; Stalboerger, PG; Du, Z; McGregor, CGA; (2011) New Carbohydrate and Membrane Protein Antigens Involved in Cardiac Xenotransplantation. In: JOURNAL OF HEART AND LUNG TRANSPLANTATION. (pp. S102 - S102). ELSEVIER SCIENCE INC

Byrne, GW; Stalboerger, PG; Du, ZJ; Davis, TR; McGregor, CGA; (2011) Identification of New Carbohydrate and Membrane Protein Antigens in Cardiac Xenotransplantation. TRANSPLANTATION , 91 (3) 287 - 292. 10.1097/TP.0b013e318203c27d.

C

Campbell, NH; Smith, DL; Reszka, AP; Neidle, S; O'Hagan, D; (2011) Fluorine in medicinal chemistry: beta-fluorination of peripheral pyrrolidines attached to acridine ligands affects their interactions with G-quadruplex DNA. ORGANIC & BIOMOLECULAR CHEMISTRY , 9 (5) pp. 1328-1331. 10.1039/c0ob00886a.

Campbelll, NH; Karim, NHA; Parkinson, GN; Vilar, R; Neidie, S; (2011) The first crystal structure of a telomeric quadruplex DNA with a metal containing ligand. CANCER RESEARCH , 71 10.1158/1538-7445.AM2011-2326.

Candilio, L; Hausenloy, DJ; Yellon, DM; (2011) Remote Ischemic Conditioning: A Clinical Trial's Update. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS , 16 (3-4) 304 - 312. 10.1177/1074248411411711.

Casale, C; Malik, SN; Lei, S; Heath, D; Marina, N; Cotena, E; Gilbey, M; ... Mohamed-Ali, V; + view all (2011) Depression in Morbid Obesity is Associated a with Worsening Metabolic Profile, not Ameliorated by Treatment with Selective Serotonin Reuptake Inhibitors. In: OBESITY SURGERY. (pp. 1015 - 1016). SPRINGER

D

Davidson, S; (2011) Flagging flora: heart disease link. NATURE , 477 (7363) 162 - 162.

Davidson, SM; (2011) A needle in a haystack: focus on "Proteomic alterations of distinct mitochondrial subpopulations in the type 1 diabetic heart". AM J PHYSIOL-REG I , 300 (2) R183 - R185. 10.1152/ajpregu.00751.2010.

Dongworth, R; Yellon, DM; Hausenloy, DJ; (2011) CYCLOPHILIN-D ABLATION OFFERS LONG-TERM PROTECTION AGAINST ACUTE MYOCARDIAL ISCHAEMIA-REPERFUSION INJURY. In: B M J PUBLISHING GROUP

F

Flett, AS; Hasleton, J; Cook, C; Hausenloy, D; Quarta, G; Anti, C; Muthurangu, V; (2011) Evaluation of Techniques for the Quantification of Myocardial Scar of Differing Etiology Using Cardiac Magnetic Resonance. JACC-CARDIOVASC IMAG , 4 (2) 150 - 156. 10.1016/j.jcmg.2010.11.015.

Flett, AS; Sado, DM; Quarta, G; Huttin, O; Hausenloy, DJ; Banypersad, SM; Pellerin, D; ... Moon, JC; + view all (2011) Aortic stenosis is as much a disease of the myocardium as of the valve - the role of diffuse myocardial fibrosis as measured by EQ-CMR. EUROPEAN HEART JOURNAL , 32 p. 777.

Flett, AS; Sado, DM; Quarta, G; Huttin, O; Hausenloy, DJ; Banypersad, SM; Pellerin, D; ... Moon, JC; + view all (2011) Aortic stenosis is as much a disease of the myocardium as of the valve - the role of diffuse myocardial fibrosis as measured by EQ-CMR. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE , 183 p. 777.

Fujita, R; Ounzain, S; Wang, ACY; Heads, RJ; Budhram-Mahadeo, VS; (2011) Hsp-27 induction requires POU4F2/Brn-3b TF in doxorubicin-treated breast cancer cells, whereas phosphorylation alters its cellular localisation following drug treatment. CELL STRESS & CHAPERONES , 16 (4) pp. 427-439. 10.1007/s12192-011-0256-8.

H

Hausenloy, DJ; (2011) Funding: International society for heart research, European section/servier research fellowship: "Pivotal in establishing my independent career in cardiovascular research". Circulation , 124 (1) 10.1161/CIR.0b013e3182137c60.

Hausenloy, DJ; Candilio, L; Laing, C; Kunst, G; Pepper, J; Kolvekar, S; Evans, R; ... Yellon, DM; + view all (2011) Effect of remote ischemic preconditioning on clinical outcomes in patients undergoing coronary artery bypass graft surgery (ERICCA): rationale and study design of a multi-centre randomized double-blinded controlled clinical trial. Clinical Research in Cardiology pp. 1-10.

Hausenloy, DJ; Lecour, S; Yellon, DM; (2011) Reperfusion Injury Salvage Kinase and Survivor Activating Factor Enhancement Prosurvival Signaling Pathways in Ischemic Postconditioning: Two Sides of the Same Coin. ANTIOXID REDOX SIGN , 14 (5) 893 - +. 10.1089/ars.2010.3360.

Hausenloy, DJ; Yellon, DM; (2011) The therapeutic potential of ischemic conditioning: an update. NAT REV CARDIOL , 8 (11) 619 - 629. 10.1038/nrcardio.2011.85.

K

Khodiyar, VK; Hill, DP; Howe, D; Berardini, TZ; Tweedie, S; Talmud, PJ; Breckenridge, R; ... Lovering, RC; + view all (2011) The representation of heart development in the gene ontology. DEV BIOL , 354 (1) 9 - 17. 10.1016/j.ydbio.2011.03.011.

L

Lim, SY; Hausenloy, DJ; Arjun, S; Price, AN; Davidson, SM; Lythgoe, MF; Yellon, DM; (2011) Mitochondrial cyclophilin-D as a potential therapeutic target for post-myocardial infarction heart failure. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE , 15 (11) pp. 2443-2451. 10.1111/j.1582-4934.2010.01235.x.

Longacre, LS; Kloner, RA; Arai, AE; Baines, CP; Bolli, R; Braunwald, E; Downey, J; ... Yellon, DM; + view all (2011) New Horizons in Cardioprotection Recommendations From the 2010 National Heart, Lung, and Blood Institute Workshop. CIRCULATION , 124 (10) 1172 - 1179. 10.1161/CIRCULATIONAHA.111.032698.

Ludman, AJ; Hausenloy, DJ; Babu, G; Hasleton, J; Venugopal, V; Boston-Griffiths, E; Yap, J; ... Yellon, DM; + view all (2011) Failure to recapture cardioprotection with high-dose atorvastatin in coronary artery bypass surgery: a randomised controlled trial. In: (pp. pp. 1387-1395). SPRINGER HEIDELBERG

Ludman, AJ; Yellon, DM; Hasleton, J; Ariti, C; Babu, GG; Boston-Griffiths, E; Venugopal, V; ... Hausenloy, DJ; + view all (2011) Effect of erythropoietin as an adjunct to primary percutaneous coronary intervention: a randomised controlled clinical trial. HEART , 97 (19) 1560 - 1565. 10.1136/hrt.2011.223867.

Ludman, AJ; Yellon, DM; Hasleton, J; Muthurangu, V; (2011) Effect of erythropoietin as an adjunct to primary percutaneous coronary intervention: a randomised controlled clinical trial (vol 97, pg 1560, 2011). HEART , 97 (21) 1812 - 1812. 10.1136/hrt.2011.223867corr1.

M

Magrane, M; (2011) UniProt Knowledgebase: a hub of integrated protein data. DATABASE-THE JOURNAL OF BIOLOGICAL DATABASES AND CURATION (ARTN bar) 10.1093/database/bar009.

McGregor, CGA; Carpentier, A; Lila, N; Logan, JS; Byrne, GW; (2011) CARDIAC XENOTRANSPLANTATION TECHNOLOGY PROVIDES MATERIALS FOR IMPROVED BIOPROSTHETIC HEART VALVES Reply. J THORAC CARDIOV SUR , 142 (1) 239 - 239. 10.1016/j.jtcvs.2011.03.017.

Meier, P; Lansky, AJ; McGregor, CGA; (2011) Who Should Treat Coronary Left Main Disease - A Battle of the Titans? CARDIOLOGY , 118 (4) pp. 233-235. 10.1159/000329398.

Mohamed-Ali, V; Arain, SNM; Lei, S; Casale, C; Sufi, P; Heath, DI; (2011) Effect of Surgical Weight Loss on Insulin Sensitivity and Lipid Profile of Metabolically Healthy Morbidly Obese Subjects. In: OBESITY. (pp. S157 - S157). NATURE PUBLISHING GROUP

Mohamed-Ali, V; Casale, C; Arain, SNM; Lei, S; Heath, DI; Marina, N; Cotena, E; ... Gray, R; + view all (2011) Prevalence and Treatment of Depression Are Differentially Associated With Pathological Obesity and Metabolically Healthy Obesity. In: OBESITY. (pp. S92 - S92). NATURE PUBLISHING GROUP

Mukherjee, UA; Ong, SB; Davidson, SM; Yellon, DM; Hausenloy, DJ; (2011) A NOVEL ROLE FOR DJ-1 IN CARDIOPROTECTION. In: B M J PUBLISHING GROUP

O

O'Brien, AJ; Terala, D; Orie, NN; Davies, NA; Zolfaghari, P; Singer, M; Clapp, LH; (2011) BK LARGE CONDUCTANCE CA(2+)-ACTIVATED K+ CHANNEL-DEFICIENT MICE ARE NOT RESISTANT TO HYPOTENSION AND DISPLAY REDUCED SURVIVAL BENEFIT FOLLOWING POLYMICROBIAL SEPSIS. SHOCK , 35 (5) 485 - 491. 10.1097/SHK.0b013e31820860f5. Gold open access

Opie, LH; Yellon, DM; Gersh, BJ; (2011) Controversies in the cardiovascular management of type 2 diabetes. HEART , 97 (1) 6 - 14. 10.1136/hrt.2010.214031.

Orie, NN; Clapp, LH; (2011) Role of prostanoid IP and EP receptors in mediating vasorelaxant responses to PGI(2) analogues in rat tail artery: Evidence for G(i/o) modulation via EP3 receptors. EUR J PHARMACOL , 654 (3) 258 - 265. 10.1016/j.ejphar.2010.12.005.

Ounzain, S; Bowen, S; Patel, C; Fujita, R; Heads, RJ; Budhram-Mahadeo, VS; (2011) Proliferation-associated POU4F2/Brn-3b transcription factor expression is regulated by oestrogen through ER alpha and growth factors via MAPK pathway. BREAST CANCER RESEARCH , 13 (1) 10.1186/bcr2809.

P

Paiva, MA; Rutter-Locher, Z; Goncalves, LM; Providencia, LA; Davidson, SM; Yellon, DM; Mocanu, MM; (2011) Enhancing AMPK activation during ischemia protects the diabetic heart against reperfusion injury. AM J PHYSIOL-HEART C , 300 (6) H2123 - H2134. 10.1152/ajpheart.00707.2010.

Pillai, MS; Sapna, S; Shivakumar, K; (2011) p38 MAPK regulates G1-S transition in hypoxic cardiac fibroblasts. Int J Biochem Cell Biol , 43 (6) pp. 919-927. 10.1016/j.biocel.2011.03.007.

Price, AN; Cheung, KK; Lim, SY; Yellon, DM; Hausenloy, DJ; Lythgoe, MF; (2011) Rapid assessment of myocardial infarct size in rodents using multi-slice inversion recovery late gadolinium enhancement CMR at 9.4T. Journal of Cardiovascular Magnetic Resonance , 13 , Article 44. 10.1186/1532-429X-13-44. Green open access
file

Q

Quarta, G; Holdright, DR; Plant, GT; Harkness, A; Hausenloy, D; Hyare, H; Moon, JC; (2011) Cardiovascular magnetic resonance in cardiac sarcoidosis with MR conditional pacemaker in situ. Journal of Cardiovascular Magnetic Resonance , 13 , Article 26. 10.1186/1532-429X-13-26. Green open access
file

R

Rees, PSC; Davidson, SM; Harding, SE; Elliott, PM; Hausenloy, DJ; Yellon, DM; (2011) The Mitochondrial Permeability Transition Pore is a Target for Pharmacological Cardioprotection in Human Hypertrophic Cardiomyopathy. In: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. (pp. B119 - B119). ELSEVIER SCIENCE INC

Rees, PSC; Hausenloy, DJ; Yellon, DM; (2011) Atorvastatin, Administered at the Onset of Reperfusion, Protects Human Myocardium Against Lethal Reperfusion Injury by Activation of the RISK pathway. In: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. (pp. B119 - B119). ELSEVIER SCIENCE INC

S

Sharma, V; Mocanu, MM; Kearney, M; Davidson, SM; Yellon, DM; (2011) ENDOTHELIAL DYSFUNCTION AND/OR IMPAIRED VASCULAR INSULIN SIGNALLING MAY HAVE A ROLE IN ISCHAEMIC PRECONDITIONING. HEART , 97 (24) 10.1136/heartjnl-2011-301156.30.

Smart, N; Bollini, S; Dube, KN; Vieira, JM; Zhou, B; Davidson, S; Yellon, D; ... Riley, PR; + view all (2011) De novo cardiomyocytes from within the activated adult heart after injury. NATURE , 474 (7353) 640 - U117. 10.1038/nature10188.

Smith, CCT; Lim, SY; Wynne, AM; Sivaraman, V; Davidson, SM; Mocanu, MM; Hausenloy, DJ; (2011) Failure of the Adipocytokine, Resistin, to Protect the Heart From Ischemia-Reperfusion Injury. J CARDIOVASC PHARM T , 16 (1) 63 - 71. 10.1177/1074248410382232.

Smith, CCT; Lim, SY; Wynne, AM; Sivaraman, V; Davidson, SM; Mocanu, MM; Hausenloy, DJ; (2011) Failure of the adipocytokine, resistin, to protect the heart from ischemia-reperfusion injury. Journal of Cardiovascular Pharmacology and Therapeutics , 16 (1) pp. 63-71. 10.1177/1074248410382232.

Smith, CCT; Yellon, DM; (2011) Adipocytokines, cardiovascular pathophysiology and myocardial protection. PHARMACOL THERAPEUT , 129 (2) 206 - 219. 10.1016/j.pharmthera.2010.09.003.

Smith, CCT; Yellon, DM; (2011) Necroptosis, necrostatins and tissue injury. J CELL MOL MED , 15 (9) 1797 - 1806. 10.1111/j.1582-4934.2011.01341.x.

Stables, MJ; Shah, S; Camon, EB; Lovering, RC; Newson, J; Bystrom, J; Farrow, S; (2011) Transcriptomic analyses of murine resolution-phase macrophages. BLOOD , 118 (26) E192-E208. 10.1182/blood-2011-04-345330.

T

Tazelaar, HD; Byrne, GW; McGregor, CGA; (2011) Comparison of Gal and non-Gal-mediated cardiac xenograft rejection. Transplantation , 91 (9) pp. 968-975. 10.1097/TP.0b013e318212c7fe.

Topilsky, Y; Hasin, T; McGregor, CGA; Park, SJ; (2011) Mitral valve regurgitation in patients supported on continuous flow pumps. Echocardiography , 28 (10) E202-E204. 10.1111/j.1540-8175.2011.01495.x.

W

Whittington, HJ; McLaughlin, CP; Hausenloy, DJ; Yellon, DM; Mocanu, MM; (2011) ENDOGENOUS PROTECTION AGAINST MYOCARDIAL ISCHAEMIA-REPERFUSION INJURY IN THE DIABETIC HEART. In: B M J PUBLISHING GROUP

This list was generated on Sun Jun 23 04:21:17 2019 BST.